Company / Book Value per Share
Akebia Therapeutics, Inc. Book Value per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.145
FY2025
5-year range
-$0.253 / $2.666
FY2021-FY2025
Trend
+157.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $0.145.
Based on SEC 10-K filings.
$0.145 in FY2025 with a 5-year CAGR of -51.2%.
Improved from -$0.166 to $0.145 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +69.9%
- 5-Year CAGR
- -51.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -51.2%, indicating a declining trend.
- In FY2025, book value per share increased 157.4% year-over-year.
- Peak book value per share was recorded in FY2020.
- Lowest book value per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.145 | +157.4% |
| FY2024 | -$0.253 | -52.2% |
| FY2023 | -$0.166 | -662.1% |
| FY2022 | $0.03 | -98.9% |
| FY2021 | $2.666 | -49.0% |
| FY2020 | $5.226 | +398.4% |
| FY2019 | $1.049 | -26.7% |
| FY2018 | $1.431 | +122.9% |
| FY2015 | -$6.238 | +85.5% |
| FY2014 | -$43.075 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026